▶ 調査レポート

がん幹細胞治療の世界市場（～2026年）
• 英文タイトル：Global Cancer Stem Cell Therapy Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。がん幹細胞治療の世界市場（～2026年） / Global Cancer Stem Cell Therapy Market Size, Status and Forecast 2020-2026 / MRC2-11QY11233資料のイメージです。• レポートコード：MRC2-11QY11233
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料はがん幹細胞治療のグローバル市場について調査・分析したレポートです。種類別（自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）市場規模、用途別（病院、クリニック、医学研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別がん幹細胞治療の競争状況、市場シェア
・世界のがん幹細胞治療市場：種類別市場規模 2015年-2020年（自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）
・世界のがん幹細胞治療市場：種類別市場規模予測 2021年-2026年（自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）
・世界のがん幹細胞治療市場：用途別市場規模 2015年-2020年（病院、クリニック、医学研究機関、その他）
・世界のがん幹細胞治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、医学研究機関、その他）
・北米のがん幹細胞治療市場分析：米国、カナダ
・ヨーロッパのがん幹細胞治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのがん幹細胞治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のがん幹細胞治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのがん幹細胞治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：AVIVA BioSciences、AdnaGen、Advanced Cell Diagnostics、Silicon Biosystems
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Cancer Stem Cell Therapy Market
The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Cancer Stem Cell Therapy Scope and Market Size
Cancer Stem Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AVIVA BioSciences
AdnaGen
Advanced Cell Diagnostics
Silicon Biosystems
…

Market segment by Type, the product can be split into
Autologous Stem Cell Transplants
Allogeneic Stem Cell Transplants
Syngeneic Stem Cell Transplants
Other
Market segment by Application, split into
Hospital
Clinic
Medical Research Institution
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Stem Cell Therapy Revenue
1.4 Market by Type
1.4.1 Global Cancer Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Autologous Stem Cell Transplants
1.4.3 Allogeneic Stem Cell Transplants
1.4.4 Syngeneic Stem Cell Transplants
1.4.5 Other
1.5 Market by Application
1.5.1 Global Cancer Stem Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical Research Institution
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Cancer Stem Cell Therapy Market Perspective (2015-2026)
2.2 Global Cancer Stem Cell Therapy Growth Trends by Regions
2.2.1 Cancer Stem Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Stem Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Stem Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Stem Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Stem Cell Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cell Therapy Players by Market Size
3.1.1 Global Top Cancer Stem Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Cancer Stem Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Stem Cell Therapy Market Concentration Ratio
3.2.1 Global Cancer Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Therapy Revenue in 2019
3.3 Cancer Stem Cell Therapy Key Players Head office and Area Served
3.4 Key Players Cancer Stem Cell Therapy Product Solution and Service
3.5 Date of Enter into Cancer Stem Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cancer Stem Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Cancer Stem Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Cancer Stem Cell Therapy Market Size by Application (2015-2020)
5.2 Global Cancer Stem Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cancer Stem Cell Therapy Market Size (2015-2020)
6.2 Cancer Stem Cell Therapy Key Players in North America (2019-2020)
6.3 North America Cancer Stem Cell Therapy Market Size by Type (2015-2020)
6.4 North America Cancer Stem Cell Therapy Market Size by Application (2015-2020)

7 Europe
7.1 Europe Cancer Stem Cell Therapy Market Size (2015-2020)
7.2 Cancer Stem Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Cancer Stem Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Cancer Stem Cell Therapy Market Size by Application (2015-2020)

8 China
8.1 China Cancer Stem Cell Therapy Market Size (2015-2020)
8.2 Cancer Stem Cell Therapy Key Players in China (2019-2020)
8.3 China Cancer Stem Cell Therapy Market Size by Type (2015-2020)
8.4 China Cancer Stem Cell Therapy Market Size by Application (2015-2020)

9 Japan
9.1 Japan Cancer Stem Cell Therapy Market Size (2015-2020)
9.2 Cancer Stem Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Cancer Stem Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Cancer Stem Cell Therapy Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Cancer Stem Cell Therapy Market Size (2015-2020)
10.2 Cancer Stem Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Stem Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Stem Cell Therapy Market Size by Application (2015-2020)

11 India
11.1 India Cancer Stem Cell Therapy Market Size (2015-2020)
11.2 Cancer Stem Cell Therapy Key Players in India (2019-2020)
11.3 India Cancer Stem Cell Therapy Market Size by Type (2015-2020)
11.4 India Cancer Stem Cell Therapy Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Cancer Stem Cell Therapy Market Size (2015-2020)
12.2 Cancer Stem Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Stem Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Cancer Stem Cell Therapy Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AVIVA BioSciences
13.1.1 AVIVA BioSciences Company Details
13.1.2 AVIVA BioSciences Business Overview
13.1.3 AVIVA BioSciences Cancer Stem Cell Therapy Introduction
13.1.4 AVIVA BioSciences Revenue in Cancer Stem Cell Therapy Business (2015-2020))
13.1.5 AVIVA BioSciences Recent Development
13.2 AdnaGen
13.2.1 AdnaGen Company Details
13.2.2 AdnaGen Business Overview
13.2.3 AdnaGen Cancer Stem Cell Therapy Introduction
13.2.4 AdnaGen Revenue in Cancer Stem Cell Therapy Business (2015-2020)
13.2.5 AdnaGen Recent Development
13.3 Advanced Cell Diagnostics
13.3.1 Advanced Cell Diagnostics Company Details
13.3.2 Advanced Cell Diagnostics Business Overview
13.3.3 Advanced Cell Diagnostics Cancer Stem Cell Therapy Introduction
13.3.4 Advanced Cell Diagnostics Revenue in Cancer Stem Cell Therapy Business (2015-2020)
13.3.5 Advanced Cell Diagnostics Recent Development
13.4 Silicon Biosystems
13.4.1 Silicon Biosystems Company Details
13.4.2 Silicon Biosystems Business Overview
13.4.3 Silicon Biosystems Cancer Stem Cell Therapy Introduction
13.4.4 Silicon Biosystems Revenue in Cancer Stem Cell Therapy Business (2015-2020)
13.4.5 Silicon Biosystems Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Cancer Stem Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Stem Cell Therapy Revenue
Table 3. Ranking of Global Top Cancer Stem Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Autologous Stem Cell Transplants
Table 6. Key Players of Allogeneic Stem Cell Transplants
Table 7. Key Players of Syngeneic Stem Cell Transplants
Table 8. Key Players of Other
Table 9. Global Cancer Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cancer Stem Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cancer Stem Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cancer Stem Cell Therapy Market Share by Regions (2015-2020)
Table 13. Global Cancer Stem Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cancer Stem Cell Therapy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cancer Stem Cell Therapy Market Growth Strategy
Table 19. Main Points Interviewed from Key Cancer Stem Cell Therapy Players
Table 20. Global Cancer Stem Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cancer Stem Cell Therapy Market Share by Players (2015-2020)
Table 22. Global Top Cancer Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cell Therapy as of 2019)
Table 23. Global Cancer Stem Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cancer Stem Cell Therapy Product Solution and Service
Table 26. Date of Enter into Cancer Stem Cell Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cancer Stem Cell Therapy Market Size Share by Type (2015-2020)
Table 30. Global Cancer Stem Cell Therapy Revenue Market Share by Type (2021-2026)
Table 31. Global Cancer Stem Cell Therapy Market Size Share by Application (2015-2020)
Table 32. Global Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cancer Stem Cell Therapy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cancer Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cancer Stem Cell Therapy Market Share (2019-2020)
Table 36. North America Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cancer Stem Cell Therapy Market Share by Type (2015-2020)
Table 38. North America Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cancer Stem Cell Therapy Market Share by Application (2015-2020)
Table 40. Europe Key Players Cancer Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cancer Stem Cell Therapy Market Share (2019-2020)
Table 42. Europe Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cancer Stem Cell Therapy Market Share by Type (2015-2020)
Table 44. Europe Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cancer Stem Cell Therapy Market Share by Application (2015-2020)
Table 46. China Key Players Cancer Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cancer Stem Cell Therapy Market Share (2019-2020)
Table 48. China Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 49. China Cancer Stem Cell Therapy Market Share by Type (2015-2020)
Table 50. China Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 51. China Cancer Stem Cell Therapy Market Share by Application (2015-2020)
Table 52. Japan Key Players Cancer Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cancer Stem Cell Therapy Market Share (2019-2020)
Table 54. Japan Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cancer Stem Cell Therapy Market Share by Type (2015-2020)
Table 56. Japan Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cancer Stem Cell Therapy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cancer Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cancer Stem Cell Therapy Market Share (2019-2020)
Table 60. Southeast Asia Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cancer Stem Cell Therapy Market Share by Type (2015-2020)
Table 62. Southeast Asia Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cancer Stem Cell Therapy Market Share by Application (2015-2020)
Table 64. India Key Players Cancer Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cancer Stem Cell Therapy Market Share (2019-2020)
Table 66. India Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 67. India Cancer Stem Cell Therapy Market Share by Type (2015-2020)
Table 68. India Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 69. India Cancer Stem Cell Therapy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cancer Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cancer Stem Cell Therapy Market Share (2019-2020)
Table 72. Central & South America Cancer Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cancer Stem Cell Therapy Market Share by Type (2015-2020)
Table 74. Central & South America Cancer Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cancer Stem Cell Therapy Market Share by Application (2015-2020)
Table 76. AVIVA BioSciences Company Details
Table 77. AVIVA BioSciences Business Overview
Table 78. AVIVA BioSciences Product
Table 79. AVIVA BioSciences Revenue in Cancer Stem Cell Therapy Business (2015-2020) (Million US$)
Table 80. AVIVA BioSciences Recent Development
Table 81. AdnaGen Company Details
Table 82. AdnaGen Business Overview
Table 83. AdnaGen Product
Table 84. AdnaGen Revenue in Cancer Stem Cell Therapy Business (2015-2020) (Million US$)
Table 85. AdnaGen Recent Development
Table 86. Advanced Cell Diagnostics Company Details
Table 87. Advanced Cell Diagnostics Business Overview
Table 88. Advanced Cell Diagnostics Product
Table 89. Advanced Cell Diagnostics Revenue in Cancer Stem Cell Therapy Business (2015-2020) (Million US$)
Table 90. Advanced Cell Diagnostics Recent Development
Table 91. Silicon Biosystems Company Details
Table 92. Silicon Biosystems Business Overview
Table 93. Silicon Biosystems Product
Table 94. Silicon Biosystems Revenue in Cancer Stem Cell Therapy Business (2015-2020) (Million US$)
Table 95. Silicon Biosystems Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Stem Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Autologous Stem Cell Transplants Features
Figure 3. Allogeneic Stem Cell Transplants Features
Figure 4. Syngeneic Stem Cell Transplants Features
Figure 5. Other Features
Figure 6. Global Cancer Stem Cell Therapy Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Medical Research Institution Case Studies
Figure 10. Other Case Studies
Figure 11. Cancer Stem Cell Therapy Report Years Considered
Figure 12. Global Cancer Stem Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Cancer Stem Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 14. Global Cancer Stem Cell Therapy Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Cancer Stem Cell Therapy Market Share by Players in 2019
Figure 17. Global Top Cancer Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cell Therapy as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Cancer Stem Cell Therapy Revenue in 2019
Figure 19. North America Cancer Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Cancer Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Cancer Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Cancer Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Cancer Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Cancer Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Cancer Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介
  • 変形性関節症における幹細胞治療の世界市場（～2026年）
    Global Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2020-2026
    MRC2-11QY04731 2020年11月20日 90Pages
    当調査資料は変形性関節症における幹細胞治療のグローバル市場について調査・分析したレポートです。種類別（単剤療法、併用療法）市場規模、用途別（変形性関節症（詳細不明）、変形性膝関節症、肩変形性関節症、股関節変形性関節症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...
  • 多発性硬化症における幹細胞治療の世界市場（～2026年）
    Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2020-2026
    MRC2-11QY04730 2020年11月20日 97Pages
    当調査資料は多発性硬化症における幹細胞治療のグローバル市場について調査・分析したレポートです。種類別（静脈内、脳室内）市場規模、用途別（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症（SPMS）、進行型再発性多発性硬化症（PRMS））市場規模、地域別...
  • 糖尿病・関連疾患用幹細胞療法の世界市場（～2026年）
    Global Stem Cell Therapy for Diabetes and Related Conditions Market Size, Status and Forecast 2020-2026
    MRC2-11QY04729 2020年11月20日 94Pages
    当調査資料は糖尿病・関連疾患用幹細胞療法のグローバル市場について調査・分析したレポートです。種類別（単剤療法、併用療法）市場規模、用途別（1型糖尿病、2型糖尿病、糖尿病性足潰瘍、糖尿病性腎症、糖尿病性ニューロパチー）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...
  • 犬幹細胞治療の世界市場（～2026年）
    Global Canine Stem Cell Therapy Market Size, Status and Forecast 2020-2026
    MRC2-11QY11241 2020年11月25日 94Pages
    当調査資料は犬幹細胞治療のグローバル市場について調査・分析したレポートです。種類別（同種幹細胞、自家幹細胞）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...
  • 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年）
    Global Circulating Tumor Cells and Cancer Stem Cells Market Size, Status and Forecast 2020-2026
    MRC2-11QY11380 2020年11月25日 96Pages
    当調査資料は循環腫瘍細胞（CTC）＆がん幹細胞のグローバル市場について調査・分析したレポートです。種類別（細胞濃縮、検出、CTC分析）市場規模、用途別（病院、NSC、医学研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...
  • 幹細胞臍帯血の世界市場（～2026年）
    Global Stem Cell Umbilical Cord Blood Market Size, Status and Forecast 2020-2026
    MRC2-11QY04732 2020年11月20日 93Pages
    当調査資料は幹細胞臍帯血のグローバル市場について調査・分析したレポートです。種類別（公的臍帯血バンク、私的臍帯血バンク）市場規模、用途別（がん・腫瘍疾患、慢性白血病、骨髄異形成症候群、血液疾患、ベータサラセミア、鎌状赤血球症、ウィスコット・アルドリッチ、ハーラー症候群、サンフィリッポ症候群）市場規模...
  • 自家幹細胞ベース治療法の世界市場（～2026年）
    Global Autologous Stem Cell Based Therapies Market Size, Status and Forecast 2020-2026
    MRC2-11QY10933 2020年11月25日 95Pages
    当調査資料は自家幹細胞ベース治療法のグローバル市場について調査・分析したレポートです。種類別（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞）市場規模、用途別（神経変性疾患、自己免疫疾患、心血管疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...
  • 幹細胞製造の世界市場（～2026年）
    Global Stem Cell Manufacturing Market Size, Status and Forecast 2020-2026
    MRC2-11QY04728 2020年11月20日 134Pages
    当調査資料は幹細胞製造のグローバル市場について調査・分析したレポートです。種類別（HSC、MSC、iPSC、ESC、機器、メディア、消耗品）市場規模、用途別（研究、ターゲット特定、治療、セルバンク）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...
  • 成体幹細胞アッセイの世界市場（～2026年）
    Global Adult Stem Cell Assay Market Size, Status and Forecast 2020-2026
    MRC2-11QY13582 2020年11月30日 96Pages
    当調査資料は成体幹細胞アッセイのグローバル市場について調査・分析したレポートです。種類別（生存率/細胞毒性、分離＆精製、細胞同定、増殖、分化、機能、アポトーシス）市場規模、用途別（再生医療＆治療法の開発、創薬＆開発、臨床研究）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...
  • 幹細胞アッセイの世界市場（～2026年）
    Global Stem Cell Assay Market Size, Status and Forecast 2020-2026
    MRC2-11QY04727 2020年11月20日 96Pages
    当調査資料は幹細胞アッセイのグローバル市場について調査・分析したレポートです。種類別（生存率、精製、識別）市場規模、用途別（再生医療、臨床研究）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南...
  • 変形性関節症における幹細胞治療の世界市場（～2026年）変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
  • 犬幹細胞治療の世界市場（～2026年）犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
  • 多発性硬化症における幹細胞治療の世界市場（～2026年）多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
  • 糖尿病・関連疾患用幹細胞療法の世界市場（～2026年）糖尿病・関連疾患用幹細胞療法の世界市場（～2026年） Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). NSI-566 is the stem cell thera…
  • 自家幹細胞ベース治療法の世界市場（～2026年）自家幹細胞ベース治療法の世界市場（～2026年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autologous Stem Cell Based Therapies Scop…